{"id":"https://openalex.org/W2139470111","doi":"https://doi.org/10.4155/bio.09.108","title":"Incurred Sample Reproducibility: Views and Recommendations by the European Bioanalysis Forum","display_name":"Incurred Sample Reproducibility: Views and Recommendations by the European Bioanalysis Forum","publication_year":2009,"publication_date":"2009-09-01","ids":{"openalex":"https://openalex.org/W2139470111","doi":"https://doi.org/10.4155/bio.09.108","mag":"2139470111","pmid":"https://pubmed.ncbi.nlm.nih.gov/21083073"},"language":"en","primary_location":{"id":"doi:10.4155/bio.09.108","doi":"https://doi.org/10.4155/bio.09.108","is_oa":false,"landing_page_url":"https://doi.org/10.4155/bio.09.108","pdf_url":null,"source":{"id":"https://openalex.org/S159955403","display_name":"Bioanalysis","issn_l":"1757-6180","issn":["1757-6180","1757-6199"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioanalysis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003076255","display_name":"Philip Timmerman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip Timmerman","raw_affiliation_strings":["Johnson & Johnson, Turnhoutseweg 30, B-2340Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson, Turnhoutseweg 30, B-2340Beerse, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086990426","display_name":"Silke L\u00fcdtke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Silke Luedtke","raw_affiliation_strings":["Boehringer-Ingelheim"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer-Ingelheim","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020386908","display_name":"Peter van Amsterdam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter van Amsterdam","raw_affiliation_strings":["Solvay Pharmaceutical"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Pharmaceutical","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052645958","display_name":"Margarete Brudny-Kloeppel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Margarete Brudny-Kloeppel","raw_affiliation_strings":["Bayer Schering Pharma AG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Schering Pharma AG","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069216492","display_name":"Berthold Lausecker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Berthold Lausecker","raw_affiliation_strings":["F. Hoffmann-La Roche"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044502481","display_name":"Stephanie Fischmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Fischmann","raw_affiliation_strings":["Abbott"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058215266","display_name":"Susanne Globig","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susanne Globig","raw_affiliation_strings":["Actelion Pharmaceuticals Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Actelion Pharmaceuticals Ltd","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110241259","display_name":"Carl-Johan Sennbro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130614","display_name":"Active Biotech (Sweden)","ror":"https://ror.org/03v3jkw12","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210130614"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Carl-Johan Sennbro","raw_affiliation_strings":["Active Biotech"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Active Biotech","institution_ids":["https://openalex.org/I4210130614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108371006","display_name":"Josep Maria Jansat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josep M Jansat","raw_affiliation_strings":["Laboratorios Almirall SA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorios Almirall SA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019104235","display_name":"Hans Mulder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans Mulder","raw_affiliation_strings":["Astellas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Elizabeth Thomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elizabeth Thomas","raw_affiliation_strings":["AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Magnus Knutsson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128638","display_name":"Ferring Pharmaceuticals (Denmark)","ror":"https://ror.org/03m7mhz19","country_code":"DK","type":"company","lineage":["https://openalex.org/I22138158","https://openalex.org/I4210128638"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Magnus Knutsson","raw_affiliation_strings":["Ferring Pharmaceuticals"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ferring Pharmaceuticals","institution_ids":["https://openalex.org/I4210128638"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020619746","display_name":"Dirk Kasel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I9732596","display_name":"Gr\u00fcnenthal Group (Germany)","ror":"https://ror.org/03r3ww479","country_code":"DE","type":"company","lineage":["https://openalex.org/I9732596"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dirk Kasel","raw_affiliation_strings":["Gr\u00fcnenthal GmbH","Grunenthal GmbH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gr\u00fcnenthal GmbH","institution_ids":["https://openalex.org/I9732596"]},{"raw_affiliation_string":"Grunenthal GmbH","institution_ids":["https://openalex.org/I9732596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075323863","display_name":"Stephen White","orcid":"https://orcid.org/0000-0003-0765-371X","observed_orcids":["https://orcid.org/0000-0003-0765-371X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen A White","raw_affiliation_strings":["Glaxo-Smithkline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxo-Smithkline","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019826228","display_name":"Morten Anders Kall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Morten Anders Kall","raw_affiliation_strings":["H Lundbeck A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H Lundbeck A/S","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014239303","display_name":"Nathalie Mokrzycki-Issartel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathalie Mokrzycki-Issartel","raw_affiliation_strings":["Merck&Co"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck&Co","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017407431","display_name":"Achim Freisleben","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113211","display_name":"Merck Serono S.A. (Switzerland)","ror":"https://ror.org/01vp49361","country_code":"CH","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210113211"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Achim Freisleben","raw_affiliation_strings":["Merck Serono"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Serono","institution_ids":["https://openalex.org/I4210113211"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Fernando Romero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Fernando Romero","raw_affiliation_strings":["Novartis Pharma AG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael Pilg\u00e5rd Andersen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Michael Pilg\u00e5rd Andersen","raw_affiliation_strings":["Novo Nordisk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078992572","display_name":"Norbert G. Knebel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Norbert Knebel","raw_affiliation_strings":["Nycomed"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nycomed","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068088677","display_name":"Marcel de Zwart","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marcel de Zwart","raw_affiliation_strings":["Schering-Plough"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schering-Plough","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033034369","display_name":"Sirpa Laakso","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sirpa Laakso","raw_affiliation_strings":["Orion Corporation Orion Pharma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orion Corporation Orion Pharma","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058302987","display_name":"Richard S Hucker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard S Hucker","raw_affiliation_strings":["Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Dietmar Schmidt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Dietmar Schmidt","raw_affiliation_strings":["Sanofi-Aventis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi-Aventis","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006151017","display_name":"Ben H. Gordon","orcid":"https://orcid.org/0000-0002-3105-6774","observed_orcids":["https://orcid.org/0000-0002-3105-6774"]},"institutions":[{"id":"https://openalex.org/I4210135308","display_name":"Servier (France)","ror":"https://ror.org/034e7c066","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210135308"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ben Gordon","raw_affiliation_strings":["Servier"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servier","institution_ids":["https://openalex.org/I4210135308"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077989287","display_name":"Richard W. Abbott","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Abbott","raw_affiliation_strings":["Shire Pharmaceuticals"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Pharmaceuticals","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Pierre Boulanger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I85722119","display_name":"UCB Pharma (Belgium)","ror":"https://ror.org/01n029866","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Pierre Boulanger","raw_affiliation_strings":["UCB Pharma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma","institution_ids":["https://openalex.org/I85722119"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":16,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.8232,"has_fulltext":false,"cited_by_count":89,"citation_normalized_percentile":{"value":0.95670313,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"1","issue":"6","first_page":"1049","last_page":"1056"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.03400000184774399,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/3607","display_name":"Medical Laboratory Technology"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bioanalytical-method-validation","display_name":"bioanalytical method validation","score":0.9150000214576721},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6470000147819519},{"id":"https://openalex.org/keywords/toxicokinetics","display_name":"toxicokinetics","score":0.9990000128746033},{"id":"https://openalex.org/keywords/academic-support","display_name":"academic support","score":0.6169999837875366}],"concepts":[{"id":"https://openalex.org/C137535248","wikidata":"https://www.wikidata.org/wiki/Q4914691","display_name":"Bioanalysis","level":2,"score":0.8913713693618774},{"id":"https://openalex.org/C198531522","wikidata":"https://www.wikidata.org/wiki/Q485146","display_name":"Sample (material)","level":2,"score":0.5616616606712341},{"id":"https://openalex.org/C2776743756","wikidata":"https://www.wikidata.org/wiki/Q5097921","display_name":"Safeguarding","level":2,"score":0.5230979919433594},{"id":"https://openalex.org/C9893847","wikidata":"https://www.wikidata.org/wiki/Q1425625","display_name":"Reproducibility","level":2,"score":0.4623628258705139},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.42498964071273804},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.4120696187019348},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.3267481327056885},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23358342051506042},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.17622080445289612},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.16643908619880676},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010599","descriptor_name":"Pharmacokinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017408","descriptor_name":"Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053000","descriptor_name":"Analytic Sample Preparation Methods","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.4155/bio.09.108","doi":"https://doi.org/10.4155/bio.09.108","is_oa":false,"landing_page_url":"https://doi.org/10.4155/bio.09.108","pdf_url":null,"source":{"id":"https://openalex.org/S159955403","display_name":"Bioanalysis","issn_l":"1757-6180","issn":["1757-6180","1757-6199"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioanalysis","raw_type":"journal-article"},{"id":"pmid:21083073","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21083073","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioanalysis","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.504800021648407,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1991671417","https://openalex.org/W2002058320","https://openalex.org/W2046877602","https://openalex.org/W2135270007","https://openalex.org/W2143715745","https://openalex.org/W3006182500"],"related_works":["https://openalex.org/W2900186284","https://openalex.org/W7096311370","https://openalex.org/W2071176716","https://openalex.org/W2135270007","https://openalex.org/W1993557000","https://openalex.org/W2108743111","https://openalex.org/W2323772903","https://openalex.org/W4391608172","https://openalex.org/W2895976397","https://openalex.org/W2001114473"],"abstract_inverted_index":{"Following":[0],"intensive":[1],"discussions,":[2],"review,":[3],"alignment":[4],"of":[5,44,51,87,117],"procedures":[6],"and":[7,100],"multiple":[8],"surveys":[9],"among":[10],"their":[11],"member":[12,69],"companies,":[13,70],"the":[14,32,42,49,52,60,64,74,88,114],"European":[15],"Bioanalysis":[16],"Forum":[17],"(EBF)":[18],"is":[19,91],"providing":[20],"a":[21,45],"recommendation":[22,36,90],"on":[23],"how":[24],"to":[25,38,92],"integrate":[26],"incurred":[27],"sample":[28],"reproducibility":[29],"(ISR)":[30],"in":[31,54,77],"bioanalytical":[33,95],"process.":[34],"The":[35,84],"aims":[37],"provide":[39,98],"guidance":[40],"throughout":[41],"lifecycle":[43],"validated":[46],"method,":[47],"including":[48],"application":[50],"method":[53],"study":[55],"support.":[56],"In":[57],"its":[58],"recommendation,":[59],"EBF":[61,68,89],"considers":[62],"both":[63],"internal":[65],"discussions":[66],"with":[67],"as":[71,73],"well":[72],"input":[75],"provided":[76],"international":[78],"meetings":[79],"where":[80],"ISR":[81],"was":[82],"discussed.":[83],"ultimate":[85],"goal":[86],"ensure":[93],"that":[94],"methods":[96],"can":[97],"accurate":[99],"reproducible":[101],"concentration":[102],"data":[103],"for":[104],"pharmacokinetic":[105],"and/or":[106],"toxicokinetic":[107],"evaluation,":[108],"without":[109],"any":[110],"compromise,":[111],"while":[112],"safeguarding":[113],"optimal":[115],"use":[116],"laboratory":[118],"resources.":[119]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}